Cubist Systematic Strategies’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,758
| Closed | -$619K | – | 3231 |
|
|
2021
Q1 | $619K | Sell |
7,758
-35,959
| -82% | -$2.81M | 0.01% | 1838 |
|
|
2020
Q4 | $3.45M | Buy |
43,717
+6,542
| +18% | +$384K | 0.05% | 635 |
|
|
2020
Q3 | $1.63M | Sell |
37,175
-36,187
| -49% | -$1.78M | 0.02% | 1030 |
|
|
2020
Q2 | $3.25M | Buy |
73,362
+35,593
| +94% | +$1.33M | 0.06% | 540 |
|
|
2020
Q1 | $1.36M | Buy |
37,769
+28,187
| +294% | +$1.6M | 0.04% | 652 |
|
|
2019
Q4 | $679K | Sell |
9,582
-16,052
| -63% | -$1.16M | 0.01% | 1376 |
|
|
2019
Q3 | $1.92M | Sell |
25,634
-1,897
| -7% | -$161K | 0.04% | 646 |
|
|
2019
Q2 | $2.22M | Buy |
+27,531
| New | +$1.94M | 0.04% | 632 |
|
|
2019
Q1 | – | Sell |
-4,715
| Closed | -$351K | – | 2490 |
|
|
2018
Q4 | $351K | Sell |
4,715
-11,177
| -70% | -$923K | 0.02% | 1174 |
|
|
2018
Q3 | $1.46M | Buy |
15,892
+5,802
| +58% | +$553K | 0.08% | 313 |
|
|
2018
Q2 | $992K | Buy |
10,090
+2,679
| +36% | +$300K | 0.05% | 492 |
|
|
2018
Q1 | $826K | Buy |
+7,411
| New | +$831K | 0.05% | 529 |
|
|
2017
Q1 | – | Sell |
-4,377
| Closed | -$345K | – | 1954 |
|
|
2016
Q4 | $345K | Buy |
+4,377
| New | +$340K | 0.03% | 883 |
|
|
2016
Q3 | – | Sell |
-5,541
| Closed | -$381K | – | 1945 |
|
|
2016
Q2 | $381K | Buy |
+5,541
| New | +$382K | 0.02% | 943 |
|
|
2015
Q2 | – | Sell |
-6,779
| Closed | -$322K | – | 2139 |
|
|
2015
Q1 | $322K | Buy |
+6,779
| New | +$300K | 0.02% | 1211 |
|
Cubist Systematic Strategies's CMD Position: Q2 2021 in Review
Cubist Systematic Strategies sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 7,758 shares — an estimated $619K sold.
Cubist Systematic Strategies first reported a position in CMD in Q1 2015 and held it in 15 quarters. The position peaked at $3.45M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Cubist Systematic Strategies reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Cubist Systematic Strategies sold 7,758 Cantel Medical Corporation shares in Q2 2021, an estimated $619K.
- Cubist Systematic Strategies first reported a position in Cantel Medical Corporation in Q1 2015 and held it in 15 quarters.
- Cubist Systematic Strategies's Cantel Medical Corporation position peaked at $3.45M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.